Regulators of cell competition through Toll/NF-κB are of particular relevance to cancer: elevated Toll/NF-κB signalling has been observed in various tumour types including breast cancer [51], lung cancer [52], leukaemias [53], and lymphomas [54]. This evidence concerns the gene NFKB1 and lung carcinoma.